| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £172.54M | 8.62 | 59.02% | 5.98% | 17.88% | 28.90% | |
69 Neutral | £190.28M | 7.70 | 12.15% | 3.91% | 8.31% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £357.06M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
60 Neutral | £142.45M | -138.94 | 1.15% | 2.75% | 20.73% | -89.53% | |
54 Neutral | £360.99M | -45.29 | 0.58% | 2.31% | 10.68% | -89.58% | |
41 Neutral | £359.93M | -0.78 | -142.88% | ― | -7.30% | -311.68% |